8 results
10-Q
2022 Q1
HLVX
HilleVax Inc
8 Jun 22
Quarterly report
4:25pm
informed consents, the risk that enrolled subjects will not complete a clinical trial, our ability to recruit clinical trial investigators … prove costly. The timing of our clinical trials depends, in part, on the speed at which we can recruit subjects to participate in our trials, as well
424B4
HLVX
HilleVax Inc
29 Apr 22
Prospectus supplement with pricing info
4:02pm
a clinical trial, our ability to recruit clinical trial investigators with the appropriate competencies and experience, and competing clinical trials … , on the speed at which we can recruit subjects to participate in our trials, as well as completion of required follow-up periods. The eligibility
S-1/A
HLVX
HilleVax Inc
18 Apr 22
IPO registration (amended)
6:08am
, the risk that enrolled subjects will not complete a clinical trial, our ability to recruit clinical trial investigators with the appropriate … . The timing of our clinical trials depends, in part, on the speed at which we can recruit subjects to participate in our trials, as well as completion
S-1
zmdc95gc19cgfp
6 Apr 22
IPO registration
4:21pm
DRS/A
vjzsdq5al9r
23 Nov 21
Draft registration statement (amended)
12:00am
DRS
60noe y31
19 Oct 21
Draft registration statement
12:00am
- Prev
- 1
- Next